ロード中...
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis
The safety and efficacy of anti-programmed cell death-1 (PD-1) antibodies in patients with granulomatosis with polyangiitis (GPA) still remain unclear. An 83-year-old man with GPA that was well controlled with immunosuppressive therapy was diagnosed with a postoperative recurrence of non-small cell...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6875450/ https://ncbi.nlm.nih.gov/pubmed/31292396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3018-19 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|